Results

Total Results: 2,034 records

Showing results for "time".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
    May 01, 2013 - markers Adults with suspected gastroparesis Populations Motility Assessment • Transit time … A major outcome of interest to clinicians is the ability to characterize transit time and to diagnose … (CTT) and Total transit time (TTT) by using the SmartPill device. … Study design: Observational Model: Case Control Time Perspective: Prospective Condition(s): … , combined small and large bowel transit time and total transit time.
  2. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_recruiting.pdf
    May 29, 2025 - Decisions • Incentives – To have less advantaged represented, you need to compensate them for their time
  3. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Inclusion of NRSIs will increase the scope, time, and resources needed to complete SRs, and NRSIs pose … Presence of follow-up over time (yes [i.e., longitudinal] vs. no [i.e., cross-sectional]) 5. … The first difference (within-group) controls for time-invariant differences within the intervention … Use of interrupted time series analysis in evaluating health care quality improvements. … Reducing warfarin medication interactions: an interrupted time series evaluation.
  4. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Inclusion of NRSIs will increase the scope, time, and resources needed to complete SRs, and NRSIs pose … Presence of follow-up over time (yes [i.e., longitudinal] vs. no [i.e., cross-sectional]) 5. … The first difference (within-group) controls for time-invariant differences within the intervention … Use of interrupted time series analysis in evaluating health care quality improvements. … Reducing warfarin medication interactions: an interrupted time series evaluation.
  5. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - Thus, the time, effort, and expense to find all of the trials and studies conducted on aliskerin, to … What is the followup time? Finally, S is for setting. What are the settings of interest? … the team reads the topic development documents, they need to do additional background reading from time … to time.
  6. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-march-2023-grand-rounds-slides.pdf
    January 01, 2023 - access for many patients, provides patient and provider flexibility, is more efficient in terms of time … and/or distance; many possible • Modes (asynchronous, real-time video, and many others) • Functions … incorporate it into work tasks • Available resources including money, training, physical space, time … frequently mentioned as barriers • Available resources including money, training, physical space, time … chat to complete an evaluation survey Upcoming EPC Grand Rounds theme: Maternal Health A date and time
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
    April 09, 2025 - However, it is not clear why quality-improvement studies that do not include interrupted-time series … We excluded QI studies if they did not have a control group or an interrupted time series. … trends without a time series analysis. … Thank you for your time and consideration. We agree with your statement. … The time range considered in this draft report excludes some relevant recent studies.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
    November 01, 2024 - Kidney function o eGFR o creatinine clearance o Albumin o Blood Urea Nitrogen (BUN) • Increase time … All of the systematic reviews were published in the time period 2019 - 2024. … The primary studies were published in the time frame 2014–2023. … all high quality) Author Year; Country; Funding Source; CKD Stage Quality Design; Total N; Time … to major CV event, time to a coronary event, time to CVD, coronary artery disease, cerebrovascular
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
    May 01, 2013 - in the recent reviews but were not the focus of those reviews, observational studies done at any time … Evidence was insufficient for drawing 10 conclusions regarding improvements in OME at longer time … We did not limit the time frame for followup but were most interested in outcomes 3 months or more … number of children with OME in the short term relative to watchful waiting, less is known about its long-termeffects particularly with respect to functional outcomes.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    November 01, 2024 - Follow-up time: minimum duration of 3 months. … The primary studies were published in the time frame 2017– 2024. … All of the SRs were published in the time period 2017–2023. … Furthermore, many studies had relatively short follow-up periods, which may not fully capture the long-termeffects of periodontal therapy on diabetic outcomes.
  11. SRDR-Charter-140305 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
    June 01, 2012 - Impetus − Performing systematic reviews (SRs) is costly in  time, labor, and  money. − There is … − Meetings will be scheduled at a time when the majority of board members are anticipated to  be …  members not present at meetings will have the opportunity to vote via email within a specified time … also initiate  email discussions and will allow  members to vote via  email within a specified time
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - admission but prior to cardiac catheterization or periprocedural if the agent is initiated at the time … (Note that “upstream” and “pretreatment” refer to the time before the PCI is begun; “deferred treatment … ” refers to medications given at the same time as the PCI.) … These studies confirmed that in patients pretreated with clopidogrel, the use of bivalirudin at the time … In patients treated with clopidogrel at the time of PCI there was less major bleeding at 30 days with
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
    December 01, 2024 - What resources (e.g., cost, staff, time) are required for implementation? 4. … Study time periods are not defined. … Effect of a Real-Time Electronic Dashboard on a Rapid Response System. … alerts”[tiab] OR “real time alert”[tiab] OR predict [tiab] 2. … alerts”:ti,ab OR “real time alert”:ti,ab OR predict:ti,ab 2.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
    January 01, 2024 - The implementation of a real time early warning system using machine learning in an Australian hospital … Real-Time Machine Learning Alerts to Prevent Escalation of Care: A Nonrandomized Clustered Pragmatic … Time to antibiotic administration in case of sepsis was narratively reported. … Changes in variables over time were also incorporated into the clinical comment. … Changes in variables over time were also incorporated into the clinical comment.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
    December 14, 2017 - TEP Reviewer#5 Executive Summary Results: Please specify the time period (or range of time periods … TEP Reviewer#5 Executive Summary Results: Again, a time period (or range of time periods) needed … We have added the time frame. … Studies typically did not report emergence over time. … Was the time to death changed by morcellation approach?
  16. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - (SB-PACT) program for management of asthma in school children No high-impact potential at this time … for inclusion in this report; however, they were deemed to have no high-impact potential at this time … At the time experts offered their opinions, the annual ivacaftor cost was estimated at $294,000. … Patients treated with the drug were reported to have a longer median time to the first exacerbation … The median time to first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among
  17. No Slide Title (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_vulnerable_populations_kreps.ppt
    May 29, 2025 - populations Close, familiar, & easily accessible Easy to use Dramatic and memorable Accessible over time
  18. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
    November 01, 2021 - Stimulation59-61 and the FDA-approved external Trigeminal Nerve Stimulator.62-64 Monitoring and Long-Term … searches, we still do not expect to identify a substantial amount of data for monitoring strategies and long-term … Finally, no comparator is needed anymore for studies reporting on long-term effects, and these studies … meta-analyses in the prior report for cumulative meta-analyses • KQ 3: Monitoring strategies and long-termLong-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - that effective screening strategies may not be possible outside of high-risk populations because the time … relationship between duration of use and breast cancer risk, but risk significantly decreased with time … factors, such as duration of use or time since last use. … There was inconsistent reporting of how variables, such as time since last use, duration of use, or … Predictions of the long-term effects of OC use are necessarily based on population- based, age-specific
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - At all time points, use was higher for early invasive breast cancer, but declines were also greater … We divided women into five groups characterized by the amount of time elapsed between their cancer … Tamoxifen use decreased slightly over time, while use of AIs was relatively stable (Figure 1). … Use of tamoxifen increased slightly as time from diagnosis increased, while use of AIs declined. … That is, different women are included in each of the five time groups.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: